• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实践中乳腺诊断影像学和活检的及时性:15 年的收集、比较和定义优质乳腺癌护理。

Timeliness of Breast Diagnostic Imaging and Biopsy in Practice: 15 Years of Collecting, Comparing, and Defining Quality Breast Cancer Care.

机构信息

Surgical Oncology, Legacy Health, Portland, OR, USA.

Department of Surgery, Bellingham Regional Breast Center, University of Washington, Bellingham, WA, USA.

出版信息

Ann Surg Oncol. 2023 Oct;30(10):6070-6078. doi: 10.1245/s10434-023-13905-6. Epub 2023 Aug 1.

DOI:10.1245/s10434-023-13905-6
PMID:37528305
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10495489/
Abstract

BACKGROUND

The literature lacks well-established benchmarks for expected time between screening mammogram to diagnostic imaging and then to core needle breast biopsy.

METHODS

Timeliness of diagnostic imaging workup was evaluated using aggregate data from 2005 to 2019 submitted to The National Quality Measures for Breast Centers (NQMBC).

RESULTS

A total of 419 breast centers submitted data for 1,805,515 patients on the time from screening mammogram to diagnostic imaging. The overall time was 7 days with 75th, 25th, and 10th percentile values of 5, 10, and 13.5 days, respectively. The average time in business days decreased from 9.1 to 7.1 days (p < 0.001) over the study period with the greatest gains in poorest-performing quartiles. Screening centers and centers in the Midwest had significantly shorter time to diagnostic imaging. Time from diagnostic imaging to core needle biopsy was submitted by 406 facilities representing 386,077 patients. The average time was 6 business days, with 75th, 25th, and 10th percentiles of 4, 9, and 13.7 days, respectively. Time to biopsy improved from a mean of 9.0 to 6.3 days (p < 0.001) with the most improvement in the poorest-performing quartiles. Screening centers, centers in the Midwest, and centers in metropolitan areas had significantly shorter time to biopsy.

CONCLUSIONS

In a robust dataset, the time from screening mammogram to diagnostic imaging and from diagnostic imaging to biopsy decreased from 2005 to 2019. On average, patients could expect to have diagnostic imaging and biopsies within 1 week of abnormal results. Monitoring and comparing performance with reported data may improve quality in breast care.

摘要

背景

文献中缺乏明确的基准,用于确定从筛查乳房 X 光检查到诊断影像学检查,再到核心针活检的预期时间。

方法

使用 2005 年至 2019 年提交给国家乳房中心质量指标(NQMBC)的汇总数据评估诊断影像学检查的及时性。

结果

共有 419 家乳房中心为 1805515 名患者提交了从筛查乳房 X 光检查到诊断影像学检查的时间数据。总体时间为 7 天,第 75、25 和 10 百分位数的值分别为 5、10 和 13.5 天。在研究期间,营业日的平均时间从 9.1 天减少到 7.1 天(p<0.001),表现最差的四分位数的收益最大。筛查中心和中西部中心的诊断影像学时间更短。406 家机构提交了从诊断影像学检查到核心针活检的时间数据,代表 386077 名患者。平均时间为 6 个工作日,第 75、25 和 10 百分位数的值分别为 4、9 和 13.7 天。从诊断影像学检查到活检的时间从平均 9.0 天缩短到 6.3 天(p<0.001),表现最差的四分位数的改善最大。筛查中心、中西部中心和大都市地区的中心的活检时间更短。

结论

在一个强大的数据集,从筛查乳房 X 光检查到诊断影像学检查,从诊断影像学检查到活检的时间从 2005 年到 2019 年减少。平均而言,患者可以期望在异常结果后的 1 周内进行诊断影像学检查和活检。监测和比较与报告数据的表现可能会提高乳房护理的质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97d/10495489/a7e0816cac9c/10434_2023_13905_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97d/10495489/9e3a9b0d9cc5/10434_2023_13905_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97d/10495489/4e8990113e3b/10434_2023_13905_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97d/10495489/41d6a3f5ffbc/10434_2023_13905_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97d/10495489/13c41ab966fa/10434_2023_13905_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97d/10495489/a7e0816cac9c/10434_2023_13905_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97d/10495489/9e3a9b0d9cc5/10434_2023_13905_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97d/10495489/4e8990113e3b/10434_2023_13905_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97d/10495489/41d6a3f5ffbc/10434_2023_13905_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97d/10495489/13c41ab966fa/10434_2023_13905_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e97d/10495489/a7e0816cac9c/10434_2023_13905_Fig5_HTML.jpg

相似文献

1
Timeliness of Breast Diagnostic Imaging and Biopsy in Practice: 15 Years of Collecting, Comparing, and Defining Quality Breast Cancer Care.实践中乳腺诊断影像学和活检的及时性:15 年的收集、比较和定义优质乳腺癌护理。
Ann Surg Oncol. 2023 Oct;30(10):6070-6078. doi: 10.1245/s10434-023-13905-6. Epub 2023 Aug 1.
2
National Quality Measures for Breast Centers (NQMBC): a robust quality tool: breast center quality measures.国家乳腺中心质量指标(NQMBC):一个强有力的质量工具:乳腺中心质量指标。
Ann Surg Oncol. 2010 Feb;17(2):377-85. doi: 10.1245/s10434-009-0729-5. Epub 2009 Oct 16.
3
The Current State of Timeliness in the Breast Cancer Diagnosis Journey: Abnormal Screening to Biopsy.乳腺癌诊断过程中的及时性现状:从异常筛查到活检
Semin Ultrasound CT MR. 2023 Feb;44(1):56-61. doi: 10.1053/j.sult.2022.11.004. Epub 2022 Nov 18.
4
A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center.综合性乳腺中心乳腺癌诊治及时性的质量评价。
J Am Coll Surg. 2010 Apr;210(4):449-55. doi: 10.1016/j.jamcollsurg.2010.01.015.
5
Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.评估接受组织化评估与常规护理的女性从筛查到乳腺癌诊断的等待时间。
Br J Cancer. 2017 May 9;116(10):1254-1263. doi: 10.1038/bjc.2017.87. Epub 2017 Mar 30.
6
Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.异常屏-片和数字筛查乳腺摄影后的诊断影像学和活检途径。
Breast Cancer Res Treat. 2013 Apr;138(3):879-87. doi: 10.1007/s10549-013-2466-5. Epub 2013 Mar 8.
7
Performance benchmarks for diagnostic mammography.诊断性乳腺钼靶摄影的性能基准。
Radiology. 2005 Jun;235(3):775-90. doi: 10.1148/radiol.2353040738.
8
Evaluation of abnormal mammography results and palpable breast abnormalities.乳腺钼靶检查异常结果及可触及乳腺异常的评估。
Ann Intern Med. 2003 Aug 19;139(4):274-84. doi: 10.7326/0003-4819-139-4-200308190-00010.
9
Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands.荷兰基于人群的研究:筛查性乳房 X 光摄影检查发现异常后的乳房活检趋势。
Br J Cancer. 2013 Jul 9;109(1):242-8. doi: 10.1038/bjc.2013.253. Epub 2013 May 21.
10
Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.乳腺癌筛查中有无乳腺癌个人史女性的乳腺活检强度和结果。
JAMA Intern Med. 2018 Apr 1;178(4):458-468. doi: 10.1001/jamainternmed.2017.8549.

引用本文的文献

1
Impact of Quality Improvement Interventions on Biopsy-to-Treatment Time in Breast Cancer: Results from the PROMPT Quality Collaborative of the National Accreditation Program for Breast Centers.质量改进干预措施对乳腺癌活检至治疗时间的影响:来自国家乳腺中心认证计划PROMPT质量协作组的结果
Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-17935-0.
2
Housing Status and Cancer Screening in US Veterans.美国退伍军人的住房状况与癌症筛查
J Gen Intern Med. 2025 May;40(6):1297-1305. doi: 10.1007/s11606-024-09098-7. Epub 2025 Feb 26.
3
Comparative Analysis of Biopsy Techniques for Cervical Lymphoma: A Retrospective Cohort Review.

本文引用的文献

1
Factors associated with cancer treatment delay: a protocol for a systematic review and meta-analysis.与癌症治疗延误相关的因素:系统评价和荟萃分析方案。
BMJ Open. 2022 Jun 28;12(6):e061121. doi: 10.1136/bmjopen-2022-061121.
2
The impact of the COVID-19 pandemic on cancer care.新冠疫情对癌症护理的影响。
Nat Cancer. 2020 Jun;1(6):565-567. doi: 10.1038/s43018-020-0074-y.
3
Primary Care Continuity and Wait Times to Receiving Breast Cancer Chemotherapy: A Population-Based Retrospective Cohort Study Using CanIMPACT Data.
宫颈淋巴瘤活检技术的比较分析:一项回顾性队列研究
Perm J. 2025 Mar 14;29(1):108-113. doi: 10.7812/TPP/24.096. Epub 2025 Feb 5.
4
Time From Screening to Treatment at Accredited Breast Centers in the United States.美国经认可的乳腺中心从筛查到治疗的时间。
JCO Oncol Pract. 2025 Jun;21(6):781-790. doi: 10.1200/OP-24-00516. Epub 2024 Dec 2.
5
ASO Author Reflections: Increasing Time of Diagnosis to Breast Cancer Surgery.ASO作者反思:乳腺癌手术诊断时间的延长
Ann Surg Oncol. 2024 Jul;31(7):4541-4542. doi: 10.1245/s10434-024-15295-9. Epub 2024 Apr 29.
初级保健连续性与接受乳腺癌化疗的等待时间:使用 CanIMPACT 数据的基于人群的回顾性队列研究。
Curr Oncol. 2021 Nov 17;28(6):4786-4804. doi: 10.3390/curroncol28060405.
4
Mortality due to cancer treatment delay: systematic review and meta-analysis.癌症治疗延迟导致的死亡率:系统评价与荟萃分析
BMJ. 2020 Nov 4;371:m4087. doi: 10.1136/bmj.m4087.
5
Association of patient factors with time to treatment for breast cancer.患者因素与乳腺癌治疗时间的关系。
Breast J. 2020 Oct;26(10):1995-2001. doi: 10.1111/tbj.14046. Epub 2020 Sep 13.
6
Trends in Attaining Mammography Quality Benchmarks With Repeated Participation in a Quality Measurement Program: Going Beyond the Mammography Quality Standards Act to Address Breast Cancer Disparities.通过重复参与质量测量项目实现乳腺X线摄影质量基准的趋势:超越《乳腺X线摄影质量标准法案》以解决乳腺癌差异问题。
J Am Coll Radiol. 2020 Nov;17(11):1420-1428. doi: 10.1016/j.jacr.2020.07.019. Epub 2020 Aug 7.
7
Critical evaluation of factors contributing to time to mastectomy within a single health care system.在单一医疗体系下,对促成乳房切除术时间的各种因素进行关键性评估。
Breast J. 2020 Sep;26(9):1702-1711. doi: 10.1111/tbj.13953. Epub 2020 Jul 12.
8
Improving Wait Times and Patient Experience Through Implementation of a Provincial Expedited Diagnostic Pathway for BI-RADS 5 Breast Lesions.通过实施省级 BI-RADS 5 乳腺病变快速诊断途径来改善等待时间和患者体验。
Ann Surg Oncol. 2019 Oct;26(10):3361-3367. doi: 10.1245/s10434-019-07558-7. Epub 2019 Jul 24.
9
Impact of Breast Center Accreditation on Compliance with Breast Quality Performance Measures at Commission on Cancer-Accredited Centers.乳腺中心认证对肿瘤委员会认证中心乳腺质量绩效指标合规性的影响。
Ann Surg Oncol. 2019 May;26(5):1202-1211. doi: 10.1245/s10434-018-07108-7. Epub 2019 Jan 25.
10
Radiology as the Point of Cancer Patient and Care Team Engagement: Applying the 4R Model at a Patient's Breast Cancer Care Initiation.放射科作为癌症患者与护理团队互动的切入点:在患者乳腺癌护理启动阶段应用4R模型
J Am Coll Radiol. 2016 Dec;13(12 Pt B):1579-1589. doi: 10.1016/j.jacr.2016.09.008.